HPV16 E4 Inhibitors
HPV16 E4 inhibitors encompass a class of chemicals that interfere with the human papillomavirus (HPV) type 16 E4 protein. This protein is implicated in the disassembly of the host cell's cytoskeleton and plays a crucial role in the virus life cycle, particularly in the release and transmission of the virus. The above-mentioned chemicals are known to affect various cellular pathways and processes, such as the dynamics of microtubules and actin filaments, which are integral to the structural organization and motility of cells. By disrupting these pathways, these compounds can alter the intracellular environment and potentially inhibit the functions of the E4 protein.
These inhibitors operate by targeting the stabilization and polymerization of cytoskeletal components such as microtubules and actin, which are essential for various stages of the HPV life cycle, including virus assembly, maturation, and release. For instance, compounds like curcumin, paclitaxel, and podophyllotoxin have effects on microtubule dynamics, which could be critical for the movement of virus particles within the host cell. Others, like jasplakinolide and cytochalasin D, target the actin cytoskeleton, which is also believed to be manipulated by the HPV16 E4 protein. Moreover, the signaling pathways, particularly those modulated by kinases such as ROCK, MEK, JNK, and p38 MAPK, are crucial for the regulation of cellular processes that might be exploited by HPV16 E4. Inhibitors of these kinases, therefore, may indirectly influence the function of the E4 protein, potentially disrupting the life cycle of HPV16 at stages where E4 is active.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin disrupts cytoskeletal dynamics by inhibiting the assembly of microtubules and actin filaments, potentially altering the intracellular environment necessary for HPV16 E4 function. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and prevents their disassembly, which can interfere with virus replication and assembly, processes in which the HPV16 E4 protein is involved. | ||||||
Podophyllotoxin | 518-28-5 | sc-204853 | 100 mg | $84.00 | 1 | |
Podophyllotoxin binds to tubulin and inhibits its polymerization, thereby affecting microtubule assembly which can disrupt HPV16 E4 related processes. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and prevents their depolymerization, potentially hindering cytoskeletal changes required for HPV16 E4 activities. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D blocks the polymerization of actin, affecting cell shape and motility, which may impact the HPV16 E4 protein's role in virus release and transmission. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Withaferin A is a steroidal lactone that can bind to intermediate filaments, potentially disrupting the cellular structures needed for the HPV16 E4 protein to function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that affects actin cytoskeleton organization, possibly altering the environment that HPV16 E4 requires to assist in virus release. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin inhibits myosin II, an element in cellular contractility and motility, which may influence processes associated with HPV16 E4. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is a myosin light chain kinase inhibitor that affects cell motility and structure, which can impact HPV16 E4's role in the life cycle of the virus. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor that can interfere with the MAPK/ERK pathway, potentially affecting transcription factors and cellular responses that could indirectly affect HPV16 E4 protein functions. | ||||||